1. Home
  2. ATOS vs SLNG Comparison

ATOS vs SLNG Comparison

Compare ATOS & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • SLNG
  • Stock Information
  • Founded
  • ATOS 2009
  • SLNG 2013
  • Country
  • ATOS United States
  • SLNG United States
  • Employees
  • ATOS N/A
  • SLNG N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • ATOS Health Care
  • SLNG Utilities
  • Exchange
  • ATOS Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • ATOS 96.8M
  • SLNG 81.1M
  • IPO Year
  • ATOS 2012
  • SLNG N/A
  • Fundamental
  • Price
  • ATOS $0.89
  • SLNG $5.46
  • Analyst Decision
  • ATOS Strong Buy
  • SLNG Strong Buy
  • Analyst Count
  • ATOS 3
  • SLNG 1
  • Target Price
  • ATOS $7.13
  • SLNG $12.00
  • AVG Volume (30 Days)
  • ATOS 611.2K
  • SLNG 19.5K
  • Earning Date
  • ATOS 05-13-2025
  • SLNG 05-07-2025
  • Dividend Yield
  • ATOS N/A
  • SLNG N/A
  • EPS Growth
  • ATOS N/A
  • SLNG 201.19
  • EPS
  • ATOS N/A
  • SLNG 0.08
  • Revenue
  • ATOS N/A
  • SLNG $70,861,000.00
  • Revenue This Year
  • ATOS N/A
  • SLNG $8.97
  • Revenue Next Year
  • ATOS N/A
  • SLNG $6.90
  • P/E Ratio
  • ATOS N/A
  • SLNG $65.69
  • Revenue Growth
  • ATOS N/A
  • SLNG 7.30
  • 52 Week Low
  • ATOS $0.55
  • SLNG $3.71
  • 52 Week High
  • ATOS $1.74
  • SLNG $8.28
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 64.44
  • SLNG 52.05
  • Support Level
  • ATOS $0.78
  • SLNG $5.33
  • Resistance Level
  • ATOS $0.92
  • SLNG $6.00
  • Average True Range (ATR)
  • ATOS 0.06
  • SLNG 0.36
  • MACD
  • ATOS 0.01
  • SLNG -0.02
  • Stochastic Oscillator
  • ATOS 81.82
  • SLNG 44.90

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: